AsthmaBrain Status
The company received an undisclosed amount of development capital from Muir Equity in 2015.
Developer of application to predict and prevent asthma attacks by using historical and perpetual analysis of patient populations to identify asthma-related risks. The company's Neural Intelligence Systems (NIS) enable payors, providers and patients to predict and prevent asthma attacks, simply and organically, using real-time data, unique deep learning technology and automated alerts.
Year Founded
2015
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Privately Held (backing)
-
Financing Status
Private Equity-Backed
AsthmaBrain News and Updates
'A shadow of myself': Patient urges doctors to listen to struggling COVID-19 long-haulers
CBC.ca | April 9, 2021
3 Health Conditions That Stormy Weather Can Make Worse
Health Essentials from Cleveland Clinic | January 25, 2021
Autistic man whose sentence is being questioned tests positive for COVID-19
TheGrio | January 11, 2021
Shepherd's Purse: Benefits, Side Effects, and Preparations
Verywell Health | December 7, 2020
Study suggests a role for the hypothalamus in genetic susceptibility to IBD - News
News-Medical.Net | October 29, 2020
A third of American parents don't plan to get their kids a flu vaccine
Business Insider | September 29, 2020
AsthmaBrain's Verticals
AsthmaBrain Primary Industry Sector / Group / Code
AsthmaBrain's Trends
Headquarters
-
HQ Address Line 11311 Sutter Street
-
HQ Address Line 2Suite 202
-
HQ CitySan Francisco
-
HQ State/ProvinceCalifornia
-
HQ Post Code94109
-
HQ CountryUnited States
AsthmaBrain's Keywords
mood_badFeed is empty.
Add a review